12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

XTL-001 combination of two human monoclonal antibodies against different HBsAg epitopes regulatory update

XTL received U.S. Patent No. 6,146,629 covering human monoclonal antibodies against the hepatitis B surface antigen (HBsAg)...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >